Identification and SAR exploration of a novel series of Legumain inhibitors

Research output: Contribution to journalArticle

Abstract

This letter describes the development of a series of potent and selective small molecule Legumain inhibitors suitable as chemical probes for in vitro experiments. Our previous research had identified a dipeptide inhibitor utilizing a semi-reversible cyano warhead that generated 2, a cell active inhibitor. This work explores an alternative P2-P3 linker and further SAR exploration of the P3 group which led to the identification of 16i, a highly potent inhibitor with excellent physiochemical properties.

Original languageEnglish
Pages (from-to)1546-1548
Number of pages3
JournalBioorganic & Medicinal Chemistry Letters
Volume29
Issue number12
Early online date29 Mar 2019
DOIs
Publication statusPublished - 15 Jun 2019

Fingerprint

asparaginylendopeptidase
Dipeptides
Molecules
Research
Experiments
In Vitro Techniques

Bibliographical note

Crown Copyright © 2019. Published by Elsevier Ltd. All rights reserved.

Cite this

@article{6e5b121a75834d49b4a1274a6390d5e0,
title = "Identification and SAR exploration of a novel series of Legumain inhibitors",
abstract = "This letter describes the development of a series of potent and selective small molecule Legumain inhibitors suitable as chemical probes for in vitro experiments. Our previous research had identified a dipeptide inhibitor utilizing a semi-reversible cyano warhead that generated 2, a cell active inhibitor. This work explores an alternative P2-P3 linker and further SAR exploration of the P3 group which led to the identification of 16i, a highly potent inhibitor with excellent physiochemical properties.",
author = "Eddie, {Sharon L} and Aaron Gregson and Emma Graham and Stephanie Burton and Timothy Harrison and Roberta Burden and Scott, {Christopher J} and Mullan, {Paul B} and Rich Williams",
note = "Crown Copyright {\circledC} 2019. Published by Elsevier Ltd. All rights reserved.",
year = "2019",
month = "6",
day = "15",
doi = "10.1016/j.bmcl.2019.03.019",
language = "English",
volume = "29",
pages = "1546--1548",
journal = "Bioorganic and Medicinal Chemistry Letters",
issn = "0960-894X",
publisher = "Elsevier Limited",
number = "12",

}

Identification and SAR exploration of a novel series of Legumain inhibitors. / Eddie, Sharon L; Gregson, Aaron; Graham, Emma; Burton, Stephanie; Harrison, Timothy; Burden, Roberta; Scott, Christopher J; Mullan, Paul B; Williams, Rich.

In: Bioorganic & Medicinal Chemistry Letters, Vol. 29, No. 12, 15.06.2019, p. 1546-1548.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Identification and SAR exploration of a novel series of Legumain inhibitors

AU - Eddie, Sharon L

AU - Gregson, Aaron

AU - Graham, Emma

AU - Burton, Stephanie

AU - Harrison, Timothy

AU - Burden, Roberta

AU - Scott, Christopher J

AU - Mullan, Paul B

AU - Williams, Rich

N1 - Crown Copyright © 2019. Published by Elsevier Ltd. All rights reserved.

PY - 2019/6/15

Y1 - 2019/6/15

N2 - This letter describes the development of a series of potent and selective small molecule Legumain inhibitors suitable as chemical probes for in vitro experiments. Our previous research had identified a dipeptide inhibitor utilizing a semi-reversible cyano warhead that generated 2, a cell active inhibitor. This work explores an alternative P2-P3 linker and further SAR exploration of the P3 group which led to the identification of 16i, a highly potent inhibitor with excellent physiochemical properties.

AB - This letter describes the development of a series of potent and selective small molecule Legumain inhibitors suitable as chemical probes for in vitro experiments. Our previous research had identified a dipeptide inhibitor utilizing a semi-reversible cyano warhead that generated 2, a cell active inhibitor. This work explores an alternative P2-P3 linker and further SAR exploration of the P3 group which led to the identification of 16i, a highly potent inhibitor with excellent physiochemical properties.

U2 - 10.1016/j.bmcl.2019.03.019

DO - 10.1016/j.bmcl.2019.03.019

M3 - Article

C2 - 31005445

VL - 29

SP - 1546

EP - 1548

JO - Bioorganic and Medicinal Chemistry Letters

JF - Bioorganic and Medicinal Chemistry Letters

SN - 0960-894X

IS - 12

ER -